Search research articles
Contact Us
Filters
Showing results (141-150 of 357) with videos related to
Page
of 36
Sort By:
Clinical Lung Cancer
|
July 25, 2008
An international, multicenter, randomized phase III study of first-line erlotinib followed by second-line cisplatin/gemcitabine versus first-line cisplatin/gemcitabine followed by second-line erlotinib in advanced non-small-cell lung cancer: treatment rationale and protocol dynamics of the TORCH trial
Cesare Gridelli, Charles Butts, Fortunato Ciardiello, et al.
Journal of Thoracic Disease
|
July 1, 2014
Cetuximab in advanced non-small cell lung cancer (NSCLC): the showdown?
Assunta Sgambato, Francesca Casaluce, Paolo Maione, et al.
Expert Opinion on Investigational Drugs
|
July 5, 2017
Selumetinib for the treatment of non-small cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, et al.
Cancer Treatment Reviews
|
August 13, 2013
ALK inhibitors in the treatment of advanced NSCLC
Cesare Gridelli, Solange Peters, Assunta Sgambato, et al.
Current Genomics
|
May 20, 2009
The potential role of pharmacogenomic and genomic in the adjuvant treatment of early stage non small cell lung cancer
Clorinda Schettino, Maria A Bareschino, Paolo Maione, et al.
Current Drug Targets
|
April 24, 2010
Vascular endothelial growth factor receptor as target for advanced non-small cell lung cancer therapy
Antonio Rossi, Paolo Maione, Paola Claudia Sacco, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 17, 2005
Safety profile of gefitinib in advanced non-small cell lung cancer elderly patients with chronic renal failure: two clinical cases
Antonio Rossi, Paolo Maione, Filomena Del Gaizo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 16, 2013
Reply to V. Lorusso et al
Cesare Gridelli, Ciro Gallo, Charles A Butts, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 3, 2009
Casopitant improves the quality of life in patients receiving highly emetogenic chemotherapy
Cesare Gridelli, Amin M Haiderali, Mark W Russo, et al.
Therapeutic Advances in Medical Oncology
|
September 2, 2015
Overcoming resistance to targeted therapies in NSCLC: current approaches and clinical application
Paolo Maione, Paola Claudia Sacco, Assunta Sgambato, et al.
Page
of 36
Search research articles
Search
Showing results (141-150 of 357) with videos related to
Sort By:
Page
of 36
Clinical Lung Cancer
|
July 25, 2008
An international, multicenter, randomized phase III study of first-line erlotinib followed by second-line cisplatin/gemcitabine versus first-line cisplatin/gemcitabine followed by second-line erlotinib in advanced non-small-cell lung cancer: treatment rationale and protocol dynamics of the TORCH trial
Cesare Gridelli, Charles Butts, Fortunato Ciardiello, et al.
Journal of Thoracic Disease
|
July 1, 2014
Cetuximab in advanced non-small cell lung cancer (NSCLC): the showdown?
Assunta Sgambato, Francesca Casaluce, Paolo Maione, et al.
Expert Opinion on Investigational Drugs
|
July 5, 2017
Selumetinib for the treatment of non-small cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, et al.
Cancer Treatment Reviews
|
August 13, 2013
ALK inhibitors in the treatment of advanced NSCLC
Cesare Gridelli, Solange Peters, Assunta Sgambato, et al.
Current Genomics
|
May 20, 2009
The potential role of pharmacogenomic and genomic in the adjuvant treatment of early stage non small cell lung cancer
Clorinda Schettino, Maria A Bareschino, Paolo Maione, et al.
Current Drug Targets
|
April 24, 2010
Vascular endothelial growth factor receptor as target for advanced non-small cell lung cancer therapy
Antonio Rossi, Paolo Maione, Paola Claudia Sacco, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 17, 2005
Safety profile of gefitinib in advanced non-small cell lung cancer elderly patients with chronic renal failure: two clinical cases
Antonio Rossi, Paolo Maione, Filomena Del Gaizo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 16, 2013
Reply to V. Lorusso et al
Cesare Gridelli, Ciro Gallo, Charles A Butts, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 3, 2009
Casopitant improves the quality of life in patients receiving highly emetogenic chemotherapy
Cesare Gridelli, Amin M Haiderali, Mark W Russo, et al.
Therapeutic Advances in Medical Oncology
|
September 2, 2015
Overcoming resistance to targeted therapies in NSCLC: current approaches and clinical application
Paolo Maione, Paola Claudia Sacco, Assunta Sgambato, et al.
Page
of 36